Nikko Asset Management Americas, Inc.

13F Holdings History for Arcturus Therapeutics Holdings Inc. - Common Stock, par value $0.001 per share (ARCT)

Symbol: ARCT on Nasdaq
Investment type: Equity / Common Stock, par value $0.001 per share
Latest Disclosed Ownership: 1.95M shares
Security Ownership: 7.2%

Shares, Excluding Options vs Price

Value, Excluding Options

Amova Asset Management Americas, Inc. ownership in Arcturus Therapeutics Holdings Inc. Common Stock, par value $0.001 per share (ARCT)

2025-11-13 - Amova Asset Management Americas, Inc. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 1.95M shares of Arcturus Therapeutics Holdings Inc. Common Stock, par value $0.001 per share (ARCT). This represents 7.2% percent ownership of the company. In their previous filing dated 2025-05-12, Nikko Asset Management Americas, Inc. had reported owning 1.93M shares, indicating an increase of 1.13% percent.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
Amova Asset Management Americas, Inc.	7.2%	+1.43%	$35.9M	1.95M	+21,751	+1.13%	$18.43	13G/A	9/30/2025	13 Nov 2025 09:24:54
Nikko Asset Management Americas, Inc.	7.1%		$18.9M	1.93M			$9.82	13G/A	3/31/2025	12 May 2025 14:10:00

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
9/30/2025	0.35%	+0.02%	$35.9M	1.95M	+117,632	+6.43%	$18.42	Q3 2025
6/30/2025	0.24%	-0.01%	$23.8M	1.83M	-95,881	-4.98%	$13.00	Q2 2025
3/31/2025	0.26%	-0.02%	$20.4M	1.93M	-138,966		$10.58	Q1 2025
12/31/2024	0.38%	-0.05%	$34.9M	2.07M	-250,244	-10.8%	$16.92	Q4 2024
9/30/2024	0.61%	+0.2%	$53.7M	2.32M	+752,229	+48.1%	$23.19	Q3 2024
6/30/2024	0.44%	+0.07%	$38M	1.56M	+286,546	+22.4%	$24.29	Q2 2024
3/31/2024	0.43%	-0.01%	$43M	1.28M	-44,133	-3.34%	$33.67	Q1 2024
12/31/2023	0.4%	-0.03%	$41.6M	1.32M	-67,922	-4.89%	$31.49	Q4 2023
9/30/2023	0.42%	0%	$35.4M	1.39M	-16,358	-1.16%	$25.51	Q3 2023
6/30/2023	0.42%	0%	$40.3M	1.4M	-15,469	-1.09%	$28.65	Q2 2023
3/31/2023	0.38%	-0.01%	$33M	1.42M	-28,659	-1.98%	$23.21	Q1 2023
12/31/2022	0.35%	0%	$24.6M	1.45M	-10,355	-0.71%	$16.95	Q4 2022
9/30/2022	0.27%	+0%	$21.2M	1.46M	+23,221	+1.62%	$14.50	Q3 2022
6/30/2022	0.22%	+0.01%	$18M	1.44M	+34,116	+2.43%	$12.50^*	Q2 2022
3/31/2022	0.28%	+0.01%	$37.9M	1.4M	+44,606	+3.29%	$27.00	Q1 2022
12/31/2021	0.25%	0%	$47.8M	1.36M	-1,060	-0.08%	$35.20	Q4 2021
9/30/2021	0.27%	+0.03%	$62.5M	1.36M	+143,631	+11.8%	$46.00	Q3 2021
6/30/2021	0.16%	+0.15%	$41.2M	1.21M	+899,089	+285%	$33.90	Q2 2021
3/31/2021	0.06%	+0.01%	$13M	316K	+38,126	+13.7%	$41.30	Q1 2021
12/31/2020	0.07%	+0.04%	$12M	278K	+146,516	+112%	$43.38	Q4 2020
9/30/2020	0.05%	0%	$5.63M	131K	-12,317	-8.58%	$42.90	Q3 2020
6/30/2020	0.09%	-0.07%	$6.56M	143K	-111,579	-43.7%	$45.71	Q2 2020
3/31/2020	0.06%	-0.01%	$3.47M	255K	-25,482	-9.08%	$13.59	Q1 2020
12/31/2019	0.05%	0%	$3.05M	281K	-17,982	-6.02%	$10.87	Q4 2019
9/30/2019	0.05%	+0.03%	$3.07M	299K	+168,556	+130%	$10.27	Q3 2019
6/30/2019	0.02%	+0.02%	$1.23M	130K	+129,974	NEW	$9.44	Q2 2019

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.